Quote | Health Sciences Acquisitions Corporation (NASDAQ:HSAC)
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $13.88 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 01/23/2020 04:43:43 pm |
News | Health Sciences Acquisitions Corporation (NASDAQ:HSAC)
NEW YORK, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Immunovant, Inc., (Nasdaq: IMVT) formerly known as Health Sciences Acquisitions Corporation (Nasdaq: HSAC) (“HSAC”), a special purpose acquisition company sponsored by RTW Investments, LP, announced today the closing of its business ...
NEW YORK, Dec. 02, 2019 (GLOBE NEWSWIRE) -- Health Sciences Acquisitions Corporation ("HSAC," NASDAQ: HSAC), a special purpose acquisition company sponsored by RTW Investments, LP, announced today that it has set a record date and a meeting date for the special meeting of its stockholders t...
Message Board Posts | Health Sciences Acquisitions Corporation (NASDAQ:HSAC)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Health Sciences Acquisitions Corporation Company Name:
HSAC Stock Symbol:
NASDAQ Market:
NEW YORK, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Immunovant, Inc., (Nasdaq: IMVT) formerly known as Health Sciences Acquisitions Corporation (Nasdaq: HSAC) (“HSAC”), a special purpose acquisition company sponsored by RTW Investments, LP, announced today the closing of its business ...
NEW YORK, Dec. 02, 2019 (GLOBE NEWSWIRE) -- Health Sciences Acquisitions Corporation ("HSAC," NASDAQ: HSAC), a special purpose acquisition company sponsored by RTW Investments, LP, announced today that it has set a record date and a meeting date for the special meeting of its stockholders t...
NEW YORK and LONDON , Oct. 8, 2019 /PRNewswire/ -- Health Sciences Acquisitions Corporation ("HSAC," NASDAQ: HSAC), a special purpose acquisition company sponsored by RTW Investments, and Immunovant Sciences Ltd. ("Immunovant"), a clinical-stage biopharmaceutical company focused on enab...